| Financial Year |
March 31 2023 |
| Monetary Funds |
734,374,353.22 |
| Held-for-trading Financial Assets |
90,046,666.67 |
| Notes Receivable |
28,895,345.00 |
| Accounts Receivable |
49,220,410.38 |
| Advances to Suppliers |
7,613,191.30 |
| Other Receivables |
6,303,760.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
53,605,474.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
221,523.17 |
| Total Current Assets |
979,775,415.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,976,741,720.54 |
| Investment Properties |
-- |
| Fixed Assetes |
754,478,700.93 |
| Under-construction Projects |
7,474,978.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,755,344.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,471,833.69 |
| Deferred Income Tax Assets |
393,451.17 |
| Other Non-Current Assets |
6,521,899.50 |
| Sub-Total of Non-Current Assets |
6,396,597,890.17 |
| Total Assets |
7,376,373,305.42 |
| Short-Term Loans |
43,044,015.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
161,934,710.70 |
| Accounts Payable |
70,498,320.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,715,570.97 |
| Taxes Payable |
10,545,076.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,558,502.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,406,536.20 |
| Other Current Liabilities |
5,642,443.03 |
| Sub-Total of Current Liabilities |
410,159,866.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,265,708.88 |
| Deferred Income Tax Liabilities |
216,223,351.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
236,728,017.93 |
| Total Liabilities |
646,887,884.48 |
| Paid-In Capital(Or Share Stock) |
763,440,333.00 |
| Capital Surplus |
992,825,499.87 |
| Surplus Reserve |
352,295,214.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,600,483,407.64 |
| Minority Stockholder's Interest |
20,552,867.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,708,932,553.33 |
| Owner's Equity（Stockholder's Equity） |
6,729,485,420.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,376,373,305.42 |
